Search
News
Downloads
About
Help
Contact
Entity Details
Primary name
ZN765_HUMAN
Entity type
UniProt
Source
Source Link
Details
Accession
Q7L2R6
EntryName
ZN765_HUMAN
FullName
Zinc finger protein 765
TaxID
9606
Evidence
evidence at protein level
Length
523
SequenceStatus
complete
DateCreated
2008-07-22
DateModified
2021-06-02
Ontological Relatives
Genes
ZNF765
GO terms
Show/Hide Table
GO
Name
GO:0000978
RNA polymerase II cis-regulatory region sequence-specific DNA binding
GO:0000981
DNA-binding transcription factor activity, RNA polymerase II-specific
GO:0005634
nucleus
GO:0006357
regulation of transcription by RNA polymerase II
GO:0046872
metal ion binding
Subcellular Location
Show/Hide Table
Subcellular Location
Nucleus
Domains
Show/Hide Table
Domain
Name
Category
Type
IPR001909
Krueppel-associated box
Domain
Domain
IPR013087
Zinc finger C2H2-type
Domain
Domain
IPR036051
KRAB domain superfamily
Family
Homologous superfamily
IPR036236
Zinc finger C2H2 superfamily
Family
Homologous superfamily
Diseases
Show/Hide Table
Drugs
Show/Hide Table
Interactions
15 interactions
Interactor
Partner
Sources
Publications
Link
ZN765_HUMAN
REL_HUMAN
BioGRID, IntAct
25416956
details
ZN765_HUMAN
DZIP3_HUMAN
BioGRID, IntAct
25416956
details
ZN765_HUMAN
USBP1_HUMAN
BioGRID, IntAct
25416956
details
ZN765_HUMAN
ZN581_HUMAN
BioGRID, IntAct
32296183
details
ZN765_HUMAN
UQCC2_HUMAN
BioGRID, IntAct
32296183
details
ZN765_HUMAN
BPIA1_HUMAN
BioGRID, IntAct
32296183
details
ZN765_HUMAN
INCA1_HUMAN
BioGRID, IntAct
32296183
details
ZN765_HUMAN
RUSC1_HUMAN
BioGRID, IntAct
32296183
details
ZN765_HUMAN
OTX2_HUMAN
BioGRID, IntAct
32296183
details
ZN765_HUMAN
DDT4L_HUMAN
BioGRID, IntAct
32296183
details
ZN765_HUMAN
ARI5A_HUMAN
BioGRID, IntAct
32296183
details
ZN765_HUMAN
CENPP_HUMAN
BioGRID, IntAct
32296183
details
ZN765_HUMAN
MCCD1_HUMAN
BioGRID, IntAct
32296183
details
ZN765_HUMAN
YPEL3_HUMAN
BioGRID
32296183
details
ZN765_HUMAN
TSC1_HUMAN
BioGRID
32296183
details
This website requires cookies in order to function. By using the site you are agreeing to this as outlined in our
Terms of Use
I Agree